The effect of an increasing diabetes population has resulted in escalated costs and overburdened physicians. The increase in cost is not due to the disease per se, but because of its largely preventable complications. Patient-friendly technologies are proven to significantly reduce complications and thereby cost, but seldom practised. Telemedicine is increasingly being utilized in diabetology to improve access to health care, quality of care, and clinical/psychosocial outcomes in patients with diabetes (PWD). In PWD, patient-physician interactions are essential for improving health outcomes and preventing long-term complications. Smartphones are one of the basic modalities for telemedicine application. Mobile phone messaging applications, including text messaging and multimedia message service, could offer a convenient and cost-effective way to support desirable health behaviors. There are diabetes-related mobile apps mainly focusing on self-management of diabetes, lifestyle modification, and medication adherence motivation. With the widespread availability of high-speed Internet, remote monitoring has also become popular. Home monitoring of blood glucose and blood pressure, wearable devices, and continuous glucose monitoring also play a vital role in bringing down the long‑term vascular complications of diabetes and thereby reduce the overall cost and improve the quality of life of patients. There are hundreds of tech platforms for diabetes management, of which only a few with proven efficacy and safety are recommended by physicians.
Keyphrases
- healthcare
- glycemic control
- type diabetes
- cardiovascular disease
- blood glucose
- primary care
- high speed
- blood pressure
- mental health
- risk factors
- smoking cessation
- ejection fraction
- public health
- health information
- case report
- metabolic syndrome
- end stage renal disease
- palliative care
- adipose tissue
- quality improvement
- pain management
- heart rate
- mass spectrometry
- patient reported outcomes
- prognostic factors
- atomic force microscopy
- adverse drug
- patient reported